These criteria ensure that the drug offers a genuine therapeutic difference, a requirement for its effectiveness against evolving AMR. Considering it can take 15 years and cost over $1 billion to ...

WHO releases new reports on new tests and treatments in development for bacterial infections: Geneva Saturday, October 4, 2025, 12:00 Hrs [IST] The World Health Organization (WHO) ...

The global infectious disease diagnostics market is set to witness a CAGR of ~7% in the next 5 years. Increasing prevalence ...

The World Health Organization (WHO) has released new reports on antibacterial agents in clinical and preclinical development, ...

ProteCoat™ is a non-toxic antimicrobial coating technology developed by Reactive Surfaces aimed at reducing healthcare-associated infections (HAIs) in hospitals and public spaces ...

A new study published in the journal of Infectious Disorders - Drug Targets revealed that Licorice extract gel has strong ...

Two new reports from the World Health Organization (WHO) suggest that the development of new treatments and tests for ...

CDC reports a major surge in NDM-producing carbapenem-resistant Enterobacterales infections that may defy most antibiotics.

This Collection supports and amplifies research related to SDG 3, SDG 6 and SDG 14. Antimicrobial resistance (AMR) is a global public health threat. AMR is associated with millions of deaths worldwide ...

The misuse of antibiotics has led to the rise of 'superbugs' that no longer respond to many medications. Illnesses caused by ...

Emory University launched the Emory BioFoundry Institute (EBFI), an initiative designed to empower researchers, entrepreneurs ...